CD8A and neoplasm: Histological and flow cytometric analyses conducted after patient treatment, confirmed the presence of activated CD8+ T cells and enhanced immune responses in tumour tissues, demonstrated by increased circulating CD8+ and CD4+ central memory T cells and CD8+ memory precursor effector cells (MPECs).